Published in N Engl J Med on May 13, 2010
Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop (2015) 1.11
Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc (2014) 0.95
The incidence of and risk factors for developing atypical femoral fractures in Japan. J Bone Miner Metab (2014) 0.93
Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res (2014) 0.84
Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis (2011) 0.83
Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures. Osteoporos Int (2010) 0.83
Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries. Osteoporos Int (2014) 0.82
Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality. Gastroenterol Res Pract (2013) 0.81
Long-term safety concerns of antiresorptive therapy. Rheum Dis Clin North Am (2011) 0.81
Stress fracture of the ulna associated with bisphosphonate therapy and use of walking aid. Osteoporos Int (2014) 0.79
The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates. Osteoporos Int (2015) 0.78
Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis (2015) 0.78
Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy. Arthritis Res Ther (2013) 0.77
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: sensitivity and trim and fill studies. Genet Test Mol Biomarkers (2013) 0.76
Bisphosphonates and atypical femoral fractures. N Engl J Med (2010) 0.76
Bisphosphonates and atypical subtrochanteric fractures of the femur. Bone Joint Res (2017) 0.75
Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention. Rambam Maimonides Med J (2016) 0.75
Atypical Femoral Shaft Fractures in Female Bisphosphonate Users Were Associated with an Increased Anterolateral Femoral Bow and a Thicker Lateral Cortex: A Case-Control Study. Biomed Res Int (2017) 0.75
Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series. Osteoporos Int (2017) 0.75
Vitamin D and atypical femoral fractures. Osteoporos Int (2012) 0.75
Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study. Osteoporos Int (2017) 0.75
High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates. Osteoporos Int (2017) 0.75
Sensitivity and specificity of radiographic characteristics in atypical femoral fractures. Osteoporos Int (2016) 0.75
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol (2012) 3.57
Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust (2012) 3.14
Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest (2012) 2.38
Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial. Ann Intern Med (2010) 2.29
Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2010) 1.97
No more excuses: fracture liaison services work and are cost-effective. Med J Aust (2011) 1.93
Pain, frailty and comorbidity on older men: the CHAMP study. Pain (2008) 1.79
How fast does the Grim Reaper walk? Receiver operating characteristics curve analysis in healthy men aged 70 and over. BMJ (2011) 1.59
Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests. Clin Chem (2008) 1.55
Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf) (2007) 1.55
Atypical femur fractures: a complication of prolonged bisphosphonate therapy? Med J Aust (2010) 1.40
Swimming and other sporting activities and the rate of falls in older men: longitudinal findings from the Concord Health and Ageing in Men Project. Am J Epidemiol (2014) 1.40
Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem (2007) 1.37
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med (2008) 1.29
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res (2004) 1.22
Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B. J Clin Endocrinol Metab (2010) 1.22
Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res (2010) 1.22
Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc (2011) 1.20
Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res (2011) 1.18
Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med (2009) 1.17
Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol (2007) 1.17
Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res (2004) 1.16
Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol (2006) 1.15
Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol (2008) 1.15
Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men Project. Age Ageing (2010) 1.14
The association of alanine transaminase with aging, frailty, and mortality. J Gerontol A Biol Sci Med Sci (2010) 1.14
Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol (2011) 1.14
Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone (2012) 1.11
Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab (2007) 1.07
Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J Bone Miner Res (2010) 1.07
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab (2005) 1.03
High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res (2006) 1.03
The lifestyle of our kids (LOOK) project: outline of methods. J Sci Med Sport (2007) 1.00
Risk factors for hip fracture among institutionalised older people. Age Ageing (2009) 0.98
Risk factors for fracture following a fall among older people in residential care facilities in Australia. J Am Geriatr Soc (2008) 0.98
Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci U S A (2010) 0.98
Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res (2007) 0.97
Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res (2005) 0.96
Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism. Bone (2011) 0.96
Exogenous and endogenous glucocorticoids in rheumatic diseases. Arthritis Rheum (2011) 0.95
Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis. Bone (2010) 0.94
Guilt by association? Examining the role of bisphosphonate therapy in the development of atypical femur fractures. Bone (2011) 0.94
Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab (2003) 0.93
Grb10 deletion enhances muscle cell proliferation, differentiation and GLUT4 plasma membrane translocation. J Cell Physiol (2014) 0.93
Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development (2009) 0.93
Independent and combined effects of calcium-vitamin D3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial. J Clin Endocrinol Metab (2011) 0.92
Associations between frailty and serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in older Australian men: the Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci (2013) 0.91
Associations between serum 25-hydroxyvitamin D concentrations and multiple health conditions, physical performance measures, disability, and all-cause mortality: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2014) 0.91
Analysis of the functional muscle-bone unit of the forearm in pediatric renal transplant recipients. Kidney Int (2004) 0.91
Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice. Bone (2009) 0.90
Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo. Arthritis Rheum (2009) 0.90
A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. Steroids (2010) 0.90
The challenge of continuous exogenous glucocorticoid administration in mice. Steroids (2008) 0.89
Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth. Int J Cancer (2003) 0.89
Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis. Clin Exp Metastasis (2008) 0.87
Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone. Clin Exp Metastasis (2014) 0.87
Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin Endocrinol Metab (2008) 0.87
The role of fat and lean mass in bone loss in older men: findings from the CHAMP study. Bone (2011) 0.87
More on atypical fractures of the femoral diaphysis. N Engl J Med (2008) 0.87
Sex steroids, not FSH, influence bone mass. Cell (2006) 0.86
Vitamin D deficiency promotes prostate cancer growth in bone. Prostate (2010) 0.86
The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta (2008) 0.85
Use of bone turnover markers in the real world: are we there yet? J Bone Miner Res (2009) 0.83
Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis (2011) 0.83
Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy. Arq Bras Endocrinol Metabol (2007) 0.83
Psychotropic drug use and alcohol drinking in community-dwelling older Australian men: the CHAMP study. Drug Alcohol Rev (2012) 0.83
Sunlight and health: attitudes of older people living in intermediate care facilities in southern Australia. Arch Gerontol Geriatr (2010) 0.83
Low-trauma fractures indicate increased risk of hip fracture in frail older people. J Bone Miner Res (2011) 0.82
Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing (2010) 0.82
Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing. Steroids (2010) 0.82
A selection strategy was developed for fracture reduction programs in frail older people. J Clin Epidemiol (2010) 0.82
Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Clin Lab (2006) 0.82
Associations between circulating reproductive hormones and SHBG and prevalent and incident metabolic syndrome in community-dwelling older men: the Concord Health and Ageing in Men Project. J Clin Endocrinol Metab (2014) 0.82
The effects of hormonal contraceptives on bone turnover markers and bone health. Clin Endocrinol (Oxf) (2009) 0.82
Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways. J Bone Miner Res (2014) 0.82
Longitudinal and cross-sectional relationships of circulating reproductive hormone levels to self-rated health and health-related quality of life in community-dwelling older men. J Clin Endocrinol Metab (2014) 0.81
Cross-sectional and longitudinal associations between the active vitamin D metabolite (1,25 dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men Project. Age (Dordr) (2015) 0.81
Low levels of 25-hydroxy vitamin D and active 1,25-dihydroxyvitamin D independently associated with type 2 diabetes mellitus in older Australian men: the Concord Health and Ageing in Men Project. J Am Geriatr Soc (2014) 0.81
Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis? Endocrinology (2004) 0.81
Selective glucocorticoid receptor agonists: glucocorticoid therapy with no regrets? J Bone Miner Res (2012) 0.80
Endocrine regulation of bone turnover in men. Clin Endocrinol (Oxf) (2005) 0.80
Back pain in older male Italian-born immigrants in Australia: the importance of socioeconomic factors. Eur J Pain (2010) 0.80
Estimation of lean body weight in older community-dwelling men. Br J Clin Pharmacol (2010) 0.80
Contribution of a common variant in the promoter of the 1-α-hydroxylase gene (CYP27B1) to fracture risk in the elderly. Calcif Tissue Int (2010) 0.80
Ethnicity and falls in older men: low rate of falls in Italian-born men in Australia. Age Ageing (2011) 0.80
Longitudinal relationships of circulating reproductive hormone with functional disability, muscle mass, and strength in community-dwelling older men: the Concord Health and Ageing in Men project. J Clin Endocrinol Metab (2014) 0.79
Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells. Calcif Tissue Int (2009) 0.79
Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation. Arthritis Res Ther (2013) 0.79
Delayed-onset hypoparathyroidism in an adolescent with chromosome 22Q11 deletion syndrome. Endocr Pract (2011) 0.79
Arthritis and endogenous glucocorticoids: the emerging role of the 11beta-HSD enzymes. Ann Rheum Dis (2008) 0.78
Bone turnover in elderly men: relationships to change in bone mineral density. BMC Musculoskelet Disord (2007) 0.78
Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location. Med J Aust (2009) 0.78
Depressive symptoms in older male Italian immigrants in Australia: the Concord Health and Ageing in Men Project. Med J Aust (2010) 0.78
Vitamin D status is associated with sun exposure, vitamin D and calcium intake, acculturation and attitudes in immigrant East Asian women living in Sydney. J Steroid Biochem Mol Biol (2012) 0.78
Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab (2004) 0.78
Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open (2013) 0.78